Integration of New Genetic Diseases into Statewide Newborn Screening: New England Experience

American Journal of Medical Genetics - Seminars in Medical Genetics

Volumn 125 C, Issue 1, 2004, Pages 35-41

  Comeau, Anne Marie ^a   Larson, Cecilia ^a   Eaton, Roger B ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Cystic fibrosis screening; Newborn screening; Newborn screening expansion; Tandem mass spectrometry

Indexed keywords

ALGORITHM; ARTICLE; GENETIC DISORDER; HEALTH CARE PERSONNEL; HEALTH PROGRAM; HUMAN; INFANT; MAJOR CLINICAL STUDY; NEWBORN; NEWBORN SCREENING; PRIMARY HEALTH CARE; PRIORITY JOURNAL; TANDEM MASS SPECTROMETRY; UNITED STATES;

EID: 0942298251     PISSN: 15524868     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajmg.c.30001     Document Type: Article

References (13)

1. Albers S, Waisbren SE, Ampola MG, Brewster TG, Burke LW, Demmer LA, Filiano J, Greenstein RM, Ingham CL, Korson MS, Marsden D, Schwartz RC, Seashore MR, Shih VE, Levy HL. 2001. New England Consortium: a model for medical evaluation of expanded newborn screening with tandem mass spectrometry. J Inherit Metab Dis 24:303-304.
2. Atkinson K, Zuckerman B, Sharfstein JM, Levin D, Blatt RJR, Koh HK. 2001. A public health response to emerging technology: expansion of the Massachusetts newborn screening program. Pub Health Rep 116:122-131.
3. Comeau AM, Parad RB, Dorkin HL, Dovcy M, Gerstle R, Haver K, Lapey A, O'Sullivan BF, Waltz DA, Zwerdling R, Eaton RB. 2004. Population-based newborn screening for genetic disorders when multiple mutation DNA testing is incorporated: A cystic fibrosis newborn screening model demonstrating increased sensitivity but more carrier detections. Pediatrics (in press).
4. Dussault JH, Coulombe P, Laberge C, Letarte J, Guyda H, Khoury K. 1975. Preliminary report on a mass screening program for neonatal hypothyroidism. J Pediatr 86:670-674.
5. Gregg RG, Wilfond BS, Farrell PM, Laxova A, Hassemer D, Mischler EH. 1993. Application of DNA analysis in a population-screening program for neonatal diagnosis of cystic fibrosis (CF): comparison of screening protocols. Am J Hum Genet 52:616-626.
6. MacCready R. 1963. Phenylketonuria screening program. N Engl J Med 269:52-56.
7. Massachusetts General Legislature. Chapter 111 Sections 4E, Public Health Program to combat mental retardation in children, and 110A, Tests of newborn children for treatable disorders or diseases.
8. Millington DS, Kodo N, Norwood DL, Roe CF. 1990. Tandem mass spectrometry: a new method for acylcarnitine profiling with potential for neonatal screening for inborn errors of metabolism. J Inherit Met Dis 13:321-324.
9. Naylor EW, Chace DH. 1999. Automated tandem mass spectrometry for mass newborn screening for disorders in fatty acid, organic acid, and amino acid metabolism. J Child Neurol 14(Suppl 1):S4-S8.
10. Rashed MS, Bucknall MP, Little D, Awad A, Jacob M, Alamoudi M, Alwattar M, Ozand PT. 1997. Screening blood spots for inborn errors of metabolism by electrospray tandem mass spectrometry with a microplate batch process and a computer algorithm for automated flagging of abnormal profiles. Clin Chem 43:1129-1141.
11. Wheeler PG, Smith R, Dorkin H, Parad RB, Comeau AM, Bianchi DW. 2001. Genetic counseling after implementation of statewide cystic fibrosis newborn screening: two years' experience in one medical center. Genet Med 3:411-415.
12. Wilson JMG, Jungner G. 1968. Principles and practice of screening for disease. Public health paper no. 34. Geneva: World Health Organization.
13. Zytkovicz TH, Fitzgerald EF, Marsden D, Larson CA, Shih VE, Johnson DM, Strauss AW, Comeau AM, Eaton RB, Grady GF. 2001. Tandem mass spectrometry analysis for amino acid, organic and fatty acid disorders in newborn dried blood spots: a two year summary by the New England Newborn Screening Program. Clin Chem 47:1945-1955.